Cargando…

Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases

Detalles Bibliográficos
Autores principales: Fang, Hong, Wang, Sa A., Khoury, Joseph D., El Hussein, Siba, Kim, Do Hwan, Tashakori, Mehrnoosh, Tang, Zhenya, Li, Shaoying, Hu, Zhihong, Jelloul, Fatima Zahra, Patel, Keyur P., McDonnell, Timothy J., Kadia, Tapan, Medeiros, L. Jeffrey, Wang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425316/
https://www.ncbi.nlm.nih.gov/pubmed/35511670
http://dx.doi.org/10.3324/haematol.2021.280487
_version_ 1784778420878573568
author Fang, Hong
Wang, Sa A.
Khoury, Joseph D.
El Hussein, Siba
Kim, Do Hwan
Tashakori, Mehrnoosh
Tang, Zhenya
Li, Shaoying
Hu, Zhihong
Jelloul, Fatima Zahra
Patel, Keyur P.
McDonnell, Timothy J.
Kadia, Tapan
Medeiros, L. Jeffrey
Wang, Wei
author_facet Fang, Hong
Wang, Sa A.
Khoury, Joseph D.
El Hussein, Siba
Kim, Do Hwan
Tashakori, Mehrnoosh
Tang, Zhenya
Li, Shaoying
Hu, Zhihong
Jelloul, Fatima Zahra
Patel, Keyur P.
McDonnell, Timothy J.
Kadia, Tapan
Medeiros, L. Jeffrey
Wang, Wei
author_sort Fang, Hong
collection PubMed
description
format Online
Article
Text
id pubmed-9425316
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-94253162022-09-15 Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases Fang, Hong Wang, Sa A. Khoury, Joseph D. El Hussein, Siba Kim, Do Hwan Tashakori, Mehrnoosh Tang, Zhenya Li, Shaoying Hu, Zhihong Jelloul, Fatima Zahra Patel, Keyur P. McDonnell, Timothy J. Kadia, Tapan Medeiros, L. Jeffrey Wang, Wei Haematologica Letter to the Editor Fondazione Ferrata Storti 2022-05-05 /pmc/articles/PMC9425316/ /pubmed/35511670 http://dx.doi.org/10.3324/haematol.2021.280487 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Letter to the Editor
Fang, Hong
Wang, Sa A.
Khoury, Joseph D.
El Hussein, Siba
Kim, Do Hwan
Tashakori, Mehrnoosh
Tang, Zhenya
Li, Shaoying
Hu, Zhihong
Jelloul, Fatima Zahra
Patel, Keyur P.
McDonnell, Timothy J.
Kadia, Tapan
Medeiros, L. Jeffrey
Wang, Wei
Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases
title Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases
title_full Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases
title_fullStr Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases
title_full_unstemmed Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases
title_short Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases
title_sort pure erythroid leukemia is characterized by biallelic tp53 inactivation and abnormal p53 expression patterns in de novo and secondary cases
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425316/
https://www.ncbi.nlm.nih.gov/pubmed/35511670
http://dx.doi.org/10.3324/haematol.2021.280487
work_keys_str_mv AT fanghong pureerythroidleukemiaischaracterizedbybiallelictp53inactivationandabnormalp53expressionpatternsindenovoandsecondarycases
AT wangsaa pureerythroidleukemiaischaracterizedbybiallelictp53inactivationandabnormalp53expressionpatternsindenovoandsecondarycases
AT khouryjosephd pureerythroidleukemiaischaracterizedbybiallelictp53inactivationandabnormalp53expressionpatternsindenovoandsecondarycases
AT elhusseinsiba pureerythroidleukemiaischaracterizedbybiallelictp53inactivationandabnormalp53expressionpatternsindenovoandsecondarycases
AT kimdohwan pureerythroidleukemiaischaracterizedbybiallelictp53inactivationandabnormalp53expressionpatternsindenovoandsecondarycases
AT tashakorimehrnoosh pureerythroidleukemiaischaracterizedbybiallelictp53inactivationandabnormalp53expressionpatternsindenovoandsecondarycases
AT tangzhenya pureerythroidleukemiaischaracterizedbybiallelictp53inactivationandabnormalp53expressionpatternsindenovoandsecondarycases
AT lishaoying pureerythroidleukemiaischaracterizedbybiallelictp53inactivationandabnormalp53expressionpatternsindenovoandsecondarycases
AT huzhihong pureerythroidleukemiaischaracterizedbybiallelictp53inactivationandabnormalp53expressionpatternsindenovoandsecondarycases
AT jelloulfatimazahra pureerythroidleukemiaischaracterizedbybiallelictp53inactivationandabnormalp53expressionpatternsindenovoandsecondarycases
AT patelkeyurp pureerythroidleukemiaischaracterizedbybiallelictp53inactivationandabnormalp53expressionpatternsindenovoandsecondarycases
AT mcdonnelltimothyj pureerythroidleukemiaischaracterizedbybiallelictp53inactivationandabnormalp53expressionpatternsindenovoandsecondarycases
AT kadiatapan pureerythroidleukemiaischaracterizedbybiallelictp53inactivationandabnormalp53expressionpatternsindenovoandsecondarycases
AT medeirosljeffrey pureerythroidleukemiaischaracterizedbybiallelictp53inactivationandabnormalp53expressionpatternsindenovoandsecondarycases
AT wangwei pureerythroidleukemiaischaracterizedbybiallelictp53inactivationandabnormalp53expressionpatternsindenovoandsecondarycases